Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reizenstein

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Intensive cancer chemotherapy and immunotherapy?G Mathé, P Reizenstein
Leukemia Research|January 1, 1989
Effect of CD3 antibodies on cytotoxicity against leukemic cells resistant to activated killer cellsP Reizenstein, G Vasilopoulos
Blut|April 1, 1981
Sideroblastic anemia and development of leukemiaR Hast, P Reizenstein
Acta Medica Scandinavica|January 1, 1981
Busulfan, antimetabolites, radiotherapy, and cost of treatment in chronic myelocytic leukemia. A non-controlled, non-randomized monocenter study with historical controlsC Ogier, P Reizenstein
Acta Medica Scandinavica|September 1, 1970
Effect of starvation on body composition in obesityJ Kjellberg, P Reizenstein
Lakartidningen|December 10, 1986
[The man behind the syndrome: Eli Moschkowitz. In hospitals people should be treated, not the disease]P Bernell, P Reizenstein
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Ethical problems in clinical trials concerning minimal residual tumorsS Dion, P Reizenstein
Acta Medica Scandinavica|January 1, 1977
Management of septicemia and early death in acute leukemiaB Lantz, P Reizenstein
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Adjuvant chemotherapy and the kinetic refractoriness of minimal residual tumorsP Reizenstein, G Mathé
Drugs Under Experimental and Clinical Research|January 1, 1986
Ethics and errors of clinical trials and the role and place of different types of trial: introductionG Mathé, P Reizenstein
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Intensive cancer chemotherapy and immunotherapy?G Mathé, P Reizenstein
Leukemia Research|January 1, 1989
Effect of CD3 antibodies on cytotoxicity against leukemic cells resistant to activated killer cellsP Reizenstein, G Vasilopoulos
Blut|April 1, 1981
Sideroblastic anemia and development of leukemiaR Hast, P Reizenstein
Acta Medica Scandinavica|January 1, 1981
Busulfan, antimetabolites, radiotherapy, and cost of treatment in chronic myelocytic leukemia. A non-controlled, non-randomized monocenter study with historical controlsC Ogier, P Reizenstein
Acta Medica Scandinavica|September 1, 1970
Effect of starvation on body composition in obesityJ Kjellberg, P Reizenstein
Lakartidningen|December 10, 1986
[The man behind the syndrome: Eli Moschkowitz. In hospitals people should be treated, not the disease]P Bernell, P Reizenstein
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Ethical problems in clinical trials concerning minimal residual tumorsS Dion, P Reizenstein
Acta Medica Scandinavica|January 1, 1977
Management of septicemia and early death in acute leukemiaB Lantz, P Reizenstein
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|March 1, 1989
Adjuvant chemotherapy and the kinetic refractoriness of minimal residual tumorsP Reizenstein, G Mathé
Drugs Under Experimental and Clinical Research|January 1, 1986
Ethics and errors of clinical trials and the role and place of different types of trial: introductionG Mathé, P Reizenstein
Pageof 23